IFP Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.1M Buy
2,030
+486
+31% +$251K 0.02% 734
2026
Q2
$837K Sell
1,544
-1
-0.1% -$563 0.02% 812
2026
Q1
$916K Sell
1,545
-193
-11% -$96.1K 0.02% 727
2025
Q4
$847K Buy
1,738
+184
+12% +$85.7K 0.02% 720
2025
Q3
$651K Sell
1,554
-610
-28% -$205K 0.02% 762
2025
Q2
$622K Buy
2,164
+425
+24% +$127K 0.02% 745
2025
Q1
$536K Buy
1,739
+884
+103% +$303K 0.02% 744
2024
Q4
$302K Sell
855
-194
-18% -$71.3K 0.01% 941
2024
Q3
$376K Buy
1,049
+612
+140% +$207K 0.01% 804
2024
Q2
$139K Buy
437
+33
+8% +$8.73K 0.01% 1216
2024
Q1
$92.8K Sell
404
-132
-25% -$29.8K ﹤0.01% 1326
2023
Q4
$118K Buy
536
+121
+29% +$27.9K 0.01% 1175
2023
Q3
$93.7K Sell
415
-119
-22% -$27.4K ﹤0.01% 1281
2023
Q2
$118K Buy
534
+310
+138% +$68.7K ﹤0.01% 1240
2023
Q1
$24K Sell
224
-338
-60% -$83.3K ﹤0.01% 1937
2022
Q4
$96K Sell
562
-173
-24% -$43.7K ﹤0.01% 1764
2022
Q3
$108K Buy
735
+260
+55% +$58.1K ﹤0.01% 1806
2022
Q2
$76K Hold
475
– – ﹤0.01% 1881
2022
Q1
$76K Buy
475
+437
+1,150% +$83.3K ﹤0.01% 1880
2021
Q4
$8K Hold
38
– – ﹤0.01% 2315
2021
Q3
$7K Hold
38
– – ﹤0.01% 2443
2021
Q2
$7K Hold
38
– – ﹤0.01% 2364
2021
Q1
$7K Hold
38
– – ﹤0.01% 2294
2020
Q4
$5K Hold
38
– – ﹤0.01% 2346
2020
Q3
$4K Buy
38
+11
+41% +$1.21K ﹤0.01% 2292
2020
Q2
$3K Buy
27
+18
+200% +$2.02K ﹤0.01% 2298
2020
Q1
$1K Hold
9
– – ﹤0.01% 2629
2019
Q4
$1K Hold
9
– – ﹤0.01% 2735
2019
Q3
$1K Buy
+9
New +$725 ﹤0.01% 2941
2019
Q1
– Sell
-120
Closed -$13K – 3407
2018
Q4
$13K Sell
120
-77
-39% -$8.93K ﹤0.01% 2377
2018
Q3
$25K Hold
197
– – ﹤0.01% 2344
2018
Q2
$22K Sell
197
-78
-28% -$8.57K ﹤0.01% 2416
2018
Q1
$41K Hold
275
– – ﹤0.01% 1938
2017
Q4
$41K Hold
275
– – ﹤0.01% 1958
2017
Q3
$32K Sell
275
-112
-29% -$14.3K ﹤0.01% 2302
2017
Q2
$50K Buy
387
+152
+65% +$19K ﹤0.01% 1978
2017
Q1
$32K Hold
235
– – ﹤0.01% 2201
2016
Q4
$34K Buy
235
+10
+4% +$1.28K ﹤0.01% 2109
2016
Q3
$27K Sell
225
-170
-43% -$20.4K ﹤0.01% 2220
2016
Q2
$42K Buy
+395
New +$44.1K ﹤0.01% 1885
2016
Q1
– Sell
-393
Closed -$62K – 3413
2015
Q4
$62K Buy
+393
New +$57.2K ﹤0.01% 1475

Other funds holding UTHR

IFP Advisors's UTHR Position: Q3 2026 in Review

IFP Advisors increased its United Therapeutics (UTHR) stake by 31% in Q3 2026, buying an estimated $251K and bringing the position to 2,030 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #734.

IFP Advisors first reported a position in UTHR in Q4 2015 and has held it in 41 quarters since. 771 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • IFP Advisors held 2,030 shares of United Therapeutics worth $1.1M as of Q3 2026.
  • IFP Advisors bought 486 United Therapeutics shares in Q3 2026, an estimated $251K.
  • United Therapeutics made up 0.02% of IFP Advisors's portfolio in Q3 2026, its #734 holding.
  • IFP Advisors first reported a position in United Therapeutics in Q4 2015 and has held it in 41 quarters since.
  • 771 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.